Skip to content

End-of-day closes, 30 Oct 2026Closes 30 Oct

XBI $155.98 Down −1.15%
IBB $217.61 Down −0.11%
XLV $184.87 Up +0.45%
IHI $54.59 Down −1.98%
Next FDA date: Cemdisiran, November 2026

XBI$155.98▼ −1.15%
IBB$217.61▼ −0.11%
XLV$184.87▲ +0.45%
IHI$54.59▼ −1.98%
Next FDA date:Cemdisiran, November 2026

Search drugs, companies, news and opinions

Ctrl K

Appearance

Help Academy Login Join us as a Member

Dashboard
Research
Markets
Health News
My Workspace
Network
Health Investor

Research-only launchPrediction outputs are off until a model passes its release checks. Not investment advice.

How release checks work

Competitive landscape

Drugs aimed at the same indication, from approved to preclinical.

Indication

Health News

News Feed
News archive
Experts / Opinions

Research

FDA Calendar
Catalyst Explorer
Drug Database
Approved drugs (FDA)
Predictions
CT-VCA
Digital Health

Markets

Market overview
Health sectors
Clinical specialties
Health Deals
Insider Trades

HealthTrade

About
Help
Plans
Triage AI
MedVest Academy
Community

Site

FAQ
Contact
Sitemap
Terms
Privacy

Every page is in the left menu; on phones and tablets, open it with the menu button at the top left.

HealthTrade is for research and education. Nothing on this site is investment advice.

© 2026 HealthTrade